טוען...
The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects
Coronavirus 2019 (COVID-19) has caused significant disruption to the cell and gene therapy (CGT) industry, which has historically faced substantial complexities in supply of materials, and manufacturing and logistics processes. As decision-makers shifted their priorities to COVID-19-related issues,...
שמור ב:
| הוצא לאור ב: | Drug Discov Today |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier Ltd.
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8057929/ https://ncbi.nlm.nih.gov/pubmed/33892148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2021.04.020 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|